Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | Issue: May 2014 | May 1, 2014

Page: 1 2 3 | Single Page

Share:

Filed under:Analgesics Biologics/DMARDs Conditions Drug Updates Osteoarthritis and Bone Disorders Rheumatoid Arthritis Tagged with:anti-inflammatory apremilast Biologics drug Methotrexate Osteoarthritis patient care radiograph Rheumatoid arthritis rheumatologist rheumatology Safety Tofacitinib

Related Articles

Drug UPDATES

January 17, 2011

Information on New Approvals and Medication Safety

Rheumatology Drug Updates, Trials, Safety Data

June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Drug UPDATES

March 18, 2011

Information on New Approvals and Medication Safety

Information on New Drug Approvals and Medication Safety

March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences